Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Biotech
Pharma and life sci M&A volume dropped 8% in 2024: PwC
The companies best positioned for success are those able to identify core strengths and continuously reevaluate portfolios, according to PwC.
Gabrielle Masson
Dec 12, 2024 5:00am
BioAge obesity study derailed by side effects 2 months after IPO
Dec 9, 2024 4:36am
HanxBio plans Hong Kong IPO to fund phase 2 solid tumor trial
Nov 25, 2024 9:20am
Dig into this year’s Fierce Biotech Graveyard, layoff numbers
Nov 8, 2024 9:44am
Septerna goes public with upsized offering of $288M
Oct 25, 2024 10:29am
Septerna plans $158M IPO to fund readouts for GPCR pipeline
Oct 21, 2024 8:30am
